Cargando…
Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
Hepatitis E virus (HEV) genotype 4 (HEV-4) is an emerging cause of acute hepatitis in China. Less is known about the clinical characteristics and natural history of HEV-4 than HEV genotype 3 infections in immunocompromised patients. We report transmission of HEV-4 from a deceased organ donor to 5 tr...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390757/ https://www.ncbi.nlm.nih.gov/pubmed/30789146 http://dx.doi.org/10.3201/eid2503.181563 |
_version_ | 1783398204059942912 |
---|---|
author | Sridhar, Siddharth Cheng, Vincent C.C. Wong, Shuk-Ching Yip, Cyril C.Y. Wu, Shusheng Lo, Anthony W.I. Leung, Kit-Hang Mak, Winger W.N. Cai, Jianpiao Li, Xin Chan, Jasper F.W. Lau, Susanna K.P. Woo, Patrick C.Y. Lai, Wai-Ming Kwan, Tze-Hoi Au, Timmy W.K. Lo, Chung-Mau Wong, Sally C.Y. Yuen, Kwok-Yung |
author_facet | Sridhar, Siddharth Cheng, Vincent C.C. Wong, Shuk-Ching Yip, Cyril C.Y. Wu, Shusheng Lo, Anthony W.I. Leung, Kit-Hang Mak, Winger W.N. Cai, Jianpiao Li, Xin Chan, Jasper F.W. Lau, Susanna K.P. Woo, Patrick C.Y. Lai, Wai-Ming Kwan, Tze-Hoi Au, Timmy W.K. Lo, Chung-Mau Wong, Sally C.Y. Yuen, Kwok-Yung |
author_sort | Sridhar, Siddharth |
collection | PubMed |
description | Hepatitis E virus (HEV) genotype 4 (HEV-4) is an emerging cause of acute hepatitis in China. Less is known about the clinical characteristics and natural history of HEV-4 than HEV genotype 3 infections in immunocompromised patients. We report transmission of HEV-4 from a deceased organ donor to 5 transplant recipients. The donor had been viremic but HEV IgM and IgG seronegative, and liver function test results were within reference ranges. After a mean of 52 days after transplantation, hepatitis developed in all 5 recipients; in the liver graft recipient, disease was severe and with progressive portal hypertension. Despite reduced immunosuppression, all HEV-4 infections progressed to persistent hepatitis. Four patients received ribavirin and showed evidence of response after 2 months. This study highlights the role of organ donation in HEV transmission, provides additional data on the natural history of HEV-4 infection, and points out differences between genotype 3 and 4 infections in immunocompromised patients. |
format | Online Article Text |
id | pubmed-6390757 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-63907572019-03-06 Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018 Sridhar, Siddharth Cheng, Vincent C.C. Wong, Shuk-Ching Yip, Cyril C.Y. Wu, Shusheng Lo, Anthony W.I. Leung, Kit-Hang Mak, Winger W.N. Cai, Jianpiao Li, Xin Chan, Jasper F.W. Lau, Susanna K.P. Woo, Patrick C.Y. Lai, Wai-Ming Kwan, Tze-Hoi Au, Timmy W.K. Lo, Chung-Mau Wong, Sally C.Y. Yuen, Kwok-Yung Emerg Infect Dis Synopsis Hepatitis E virus (HEV) genotype 4 (HEV-4) is an emerging cause of acute hepatitis in China. Less is known about the clinical characteristics and natural history of HEV-4 than HEV genotype 3 infections in immunocompromised patients. We report transmission of HEV-4 from a deceased organ donor to 5 transplant recipients. The donor had been viremic but HEV IgM and IgG seronegative, and liver function test results were within reference ranges. After a mean of 52 days after transplantation, hepatitis developed in all 5 recipients; in the liver graft recipient, disease was severe and with progressive portal hypertension. Despite reduced immunosuppression, all HEV-4 infections progressed to persistent hepatitis. Four patients received ribavirin and showed evidence of response after 2 months. This study highlights the role of organ donation in HEV transmission, provides additional data on the natural history of HEV-4 infection, and points out differences between genotype 3 and 4 infections in immunocompromised patients. Centers for Disease Control and Prevention 2019-03 /pmc/articles/PMC6390757/ /pubmed/30789146 http://dx.doi.org/10.3201/eid2503.181563 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Synopsis Sridhar, Siddharth Cheng, Vincent C.C. Wong, Shuk-Ching Yip, Cyril C.Y. Wu, Shusheng Lo, Anthony W.I. Leung, Kit-Hang Mak, Winger W.N. Cai, Jianpiao Li, Xin Chan, Jasper F.W. Lau, Susanna K.P. Woo, Patrick C.Y. Lai, Wai-Ming Kwan, Tze-Hoi Au, Timmy W.K. Lo, Chung-Mau Wong, Sally C.Y. Yuen, Kwok-Yung Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018 |
title | Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018 |
title_full | Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018 |
title_fullStr | Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018 |
title_full_unstemmed | Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018 |
title_short | Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018 |
title_sort | donor-derived genotype 4 hepatitis e virus infection, hong kong, china, 2018 |
topic | Synopsis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390757/ https://www.ncbi.nlm.nih.gov/pubmed/30789146 http://dx.doi.org/10.3201/eid2503.181563 |
work_keys_str_mv | AT sridharsiddharth donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT chengvincentcc donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT wongshukching donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT yipcyrilcy donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT wushusheng donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT loanthonywi donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT leungkithang donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT makwingerwn donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT caijianpiao donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT lixin donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT chanjasperfw donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT laususannakp donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT woopatrickcy donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT laiwaiming donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT kwantzehoi donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT autimmywk donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT lochungmau donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT wongsallycy donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 AT yuenkwokyung donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018 |